Nicholas Grund – Biography

Last update: April 2, 2026

Executive profile

Nicholas was President at Eurofins Transplant Genomics, and Chief Commercial Officer at Amag Pharmaceuticals.

Nicholas Grund is currently

Chief Commercial Officer at Akebia Therapeutics - View - Akebia Therapeutics org chart



Create your alert
to follow the career of Nicholas Grund.

Education

Nicholas Grund has a Master of Business Administration from Northeastern University.

They have also studied at Northeastern University :

Find more alumni from Northeastern University

The colleagues of Nicholas Grund

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Nicholas Grund has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Nicholas Grund.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Akebia Therapeutics at +1 617... and ask for Nicholas Grund.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.